-Reuters   Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.  "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...

At a time when economic wisdom is seen as lying in allowing unrestrained play of economic power and cutting social sector spending, here is a report emphasising the economic sense in addressing hunger, especially child malnutrition. It also brings out the positive impact of employment guarantee scheme, which has been a thrust area of the UPA government but has seen a cut in allocation in Budget proposals for 2012-13. The report...

Home minister P. Chidambaram has set a two-year deadline for completing the National Population Register (NPR). In a release today, his ministry said the register was “likely to be” completed by March 2014, the statement coming a day after the Union budget announced that the Aadhaar platform was ready to support payments for projects like the rural job scheme. Aadhaar, a project of the Planning Commission, is the unique number meant for...

The latest round of data on the 2011 Census shows that the country is exhibiting distinct signs of trading up as material living conditions improve for large sections of the population. Although this aggregate picture is not uniform across the country, analysts believe that the upward material mobility in society is creating the basis of a new consumer boom in the economy—serving up a perfect backdrop ahead of the presentation of...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...